Dr Noam VanderWalde speaks to ecancer at the SIOG 2019 meeting in Geneva about the use of radiation therapy in older adults.

He explains that due to the localised nature of radiation therapy, it is more likely to be able to be tolerated in patients who have a worse functional status.

Dr VanderWalde highlights the importance for radiation oncologists to become involved with geriatric research and hopes that they can make a big impact.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.